WVE News and Press, Wave Life Sciences Ltd. From 11/09/23

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

Wave Life Sciences Ltd. (WVE) is expected to report $-0.14 for Q3 2023

2023-11-08 15:07:24 ET More on Wave Life Sciences Wave Life Sciences: Excellent Early Data, Major Collaborations, Needs Cash Wave Life Sciences spikes on R&D Day Seeking Alpha’s Quant Rating on Wave Life Sciences Historical earnings data for Wave L...

CAMBRIDGE, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, will host a live webcast and conference call at 8:30 a.m. ET on Thursday, No...

Presented preclinical proof-of-concept data for new, wholly owned program targeting INHBE for metabolic disorders, including obesity, which uses Wave’s best-in-class GalNAc-siRNA capabilities and novel genetic insights from GSK WVE-006 – industry’s first-ever RNA ed...

2023-09-28 12:21:56 ET More on Wave Life Sciences Wave Life Sciences: Excellent Early Data, Major Collaborations, Needs Cash Wave Life Sciences Ltd. (WVE) Q2 2023 Earnings Call Transcript Wave Life Sciences an outperform at Raymond James on RNA editing Seekin...

CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced that Paul Bolno, MD, MBA, President and Chief Executive Off...

2023-09-22 15:00:17 ET More on the markets No Signs Of A Major Top Yet, Staying Long BofA strategists have changed their view of the S&P 500 target, up 4%. Quant stock news sentiment measure keeps improving - BofA Amazon, Disney, Boeing boosted in Wells F...

2023-09-19 09:37:00 ET Gene-editing biotechs are hard at work to create the treatments and cures of tomorrow, and any businesses that succeed are likely to be great investments. Of course, it's complicated to figure out which are going to soar and which will languish, so it makes sense for ...

2023-09-12 17:09:48 ET Summary Wave Life Sciences Ltd. develops stereopure oligonucleotides targeting disease-causing genetic mutations. The company has lead assets in phase 1/2 trials for Duchenne muscular dystrophy and Huntington's Disease. Wave has collaborations with GSK a...